Search Orphan Drug Designations and Approvals
-
Generic Name: | Interleukin-1 alpha, human recombinant |
---|---|
Date Designated: | 06/17/1991 |
Orphan Designation: | For the promotion of early engraftment in bone marrow transplantation. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Immunex Corporation 51 University Street Seattle, Washington 98101 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-